Return to site

Metabolomics Technology Market Size, Recent Trends, and Regional Growth Forecast

Growth Opportunities in Metabolomics Technology Market

· Biotechnology
Metabolomics Technology Market

The Global Metabolomics Technology Market t is expected to reach $2.39 billion, at a CAGR of 14.6% during the forecast period.

Metabolomics is a powerful and unique analytical approach for the systematic identification and quantification of small-molecule metabolites, metabolite target analysis, metabolic profiling, and metabolic fingerprinting in various biological systems and samples. In addition, manufacturers are increasingly focusing on strengthening their presence in emerging markets of APAC countries.

This Metabolomics Technology Market majorly comprises detection techniques such as mass spectrometry (MS) and nuclear magnetic resonance spectroscopy (NMR), and separation techniques such as gas chromatography.


Download PDF (Metabolomics Market):

Metabolomics Technology Market segmentation:

· based on product

· based on an indication

· based on service,

· based on regions.

The Major Players Operating in the Metabolomics Technology Market:

The Global Metabolomics Technology Market is highly competitive in nature, with the top five companies accounting for the major market share.

These leading players have primarily focused on product launches, acquisitions, agreements, collaborations, partnerships, and expansions for growth in the Metabolomic Market.

Some key players in this market are Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), Shimadzu Corporation (Japan), Metabolon Inc. (U.S.), LECO Corporation (U.S.), Biocrates Life Sciences AG (Austria), Human Metabolome Technologies, Inc. (Japan), and Waters Corporation (U.S.).

Geographical Detailed Analysis for Metabolomics Technology Market:

North America accounted for the largest share of the Metabolomics Technology Market, followed by Europe.

Easy accessibility to technologically advanced products and the presence of many leading metabolomics manufacturers in the region are driving market growth in North America.

Similarly, the rising acceptance of personalized medicines, increasing metabolomics market research

activities, and growing adoption of technologically advanced products are driving the growth of the North American Metabolomics Technology Market.

The Asia-Pacific region is expected to witness the highest growth in this market majorly due to improving biopharmaceutical research infrastructure, large population, rising healthcare needs, growing per capita income, and growing economies in Japan and India.

All Posts

Almost done…

We just sent you an email. Please click the link in the email to confirm your subscription!

OKSubscriptions powered by Strikingly